Andrea Ghez won a share of the Nobel Prize in Physics for the discovery of a supermassive compact object at the center of our galaxy (black hole).
On Oct. 6, 2020, the Nobel Foundation announced that Andrea Ghez had won a share of the Nobel…
On Oct. 6, 2020, the Nobel Foundation announced that Andrea Ghez had won a share of the Nobel…
On Oct. 6, 2020, Oragenics announced receipt of feedback to its Type B Pre-IND Meeting Request from the…
On Oct. 6, 2020, AIM ImmunoTech announced that it had received Institutional Review Board approval for the expansion…
On Oct. 6, 2020, Hologic announced that its Aptimaᆴ SARS-CoV-2 assay, which initially received Emergency Use Authorization (EUA)…
On Oct. 6, 2020, Pfizer and BioNTech announced initiation of a rolling submission to the European Medicines Agency…
On Oct. 5, 2020, the FDA awarded a research contract to the Stanford University School of Medicine to…
On Oct. 5, 2020, CLEAR, the secure identity company, and LabCorp announced a partnership to enable users of…
On Oct. 5, 2020, CLEAR, the secure identity company, and Quest Diagnostics announced a new collaboration that aimed…
On Oct. 5, 2020, Bristol-Myers and MyoKardia announced a definitive merger agreement under which Bristol Myers Squibb will…
On Oct. 5, 2020, Joe Verghese, M.B.B.S., M.S., an international leader in aging and cognition research at Albert…
On Oct. 5, 2021, the Nobel Prize in Chemistry 2020 was awarded to Benjamin List and David MacMillan…
On Oct. 2, 2020, AstraZeneca announced the phase I/II clinical trial for the COVID-19 vaccine AZD1222 had resumed…
On Oct. 2, 2020, the National Science Foundation announced investments in 24 new projects to drive future manufacturing….
On Oct. 2, 2020, the Uconn Office of the Vice President for Research (OVPR) (OVPR) announced a new…
On Oct. 2, 2020, LabCorp announced that it had received an Emergency Use Authorization (EUA) from the FDA…
On Oct. 1, 2020, the FDA approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for the first-line treatment…
On Oct. 1, 2020, widespread accurate testing for SARS-CoV-2, the virus that causes COVID-19, is one critical aspect…
On Oct. 1, 2020, american hospitals began purchasing Veklury (remdesivir) directly from the drugメs distributor. Veklury is an…
On Oct. 1, 2020, Gilead Sciences announced that it will be responsible for distributing Veklury in the U.S….
On Sept. 30, 2020, the NIH announced that it had awarded nearly $234 million to improve COVID-19 testing…
On Sept. 30, 2020, University of Oxford researchers announced they had begun a new study to explore the…
On Sept. 30, 2020, the National Science Foundation (NSF) announced that it had funded more than 80 startups…
On Sept. 30, 2020, the United Nations and its partners announced that nearly $1 billion in financing was…
On Sept. 30, 2020, Pfizer and BioNTech announced that preliminary, peer-reviewed data from their ongoing German Phase 1/2…
On Sept. 29, 2020, the CDC reported that during Aug. 2ヨSept. 5, 2020, weekly COVID-19 cases among persons…
On Sept. 29, 2020, the NIH announed that researchers had designed モminiproteinsヤ that bound tightly to the SARS-CoV-2…
On Sept. 29, 2020, a further collaboration among the Serum Institute of India (SII), Gavi and the Bill…
On Sept. 29, 2020, Regeneron announced the first data from a descriptive analysis of a seamless Phase 1/2/3…
On Sept. 29, 2020, Windtree Therapeutics announced that FDA had accepted its Investigational New Drug application for a…
On Sept. 28, 2020, Hologic announced that its Panther Fusionᆴ SARS-CoV-2 assay had received Emergency Use Authorization (EUA)…